Comparative pharmacokinetics of azlocillin and piperacillin in normal adults. - Wikidata - wikimedia - TriplyDB

Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.

Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.

http://www.wikidata.org/entity/Q33739915

about

Pharmacokinetic comparison of 5 g of azlocillin every 8 h and 4 g every 6 h in healthy volunteers.Applications of minimal physiologically-based pharmacokinetic models.Pharmacodynamic interactions of ciprofloxacin, piperacillin, and piperacillin/tazobactam in healthy volunteers.

P2860

Q35332949-4857B7A3-32CE-4FDA-AB26-305A50058FA6 Q36517093-07233987-4268-485C-8C8E-5B61A7167257 Q52231066-3E56DC50-C526-4D86-B28F-EE4042824612

P2860

Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.

http://www.wikidata.org/entity/Q33739915

description

1986 nî lūn-bûn

@nan

1986 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1986 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1986年の論文

@ja

1986年論文

@yue

1986年論文

@zh-hant

1986年論文

@zh-hk

1986年論文

@zh-mo

1986年論文

@zh-tw

1986年论文

@wuu

name

Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.

@ast

Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.

@en

type

label

Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.

@ast

Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.

@en

prefLabel

Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.

@ast

Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.

@en

P1433

Q33739915-D0797ADA-F878-434B-B952-32FC12A95C56

P1476

Q33739915-0601BF95-379D-4452-B385-E90695FA5B25

P2093

Q33739915-0B4616D3-E8DB-4134-8416-73AE673FB4B1

Q33739915-48F654DC-0F63-40FB-8091-9C5E8683D161

Q33739915-4DC46F60-1911-45ED-9E26-4CEF6FFBD2ED

Q33739915-6285589C-0257-41A6-9A92-90662E8674C0

Q33739915-7B453190-7E6C-4408-9349-D43A4F4AE5A0

Q33739915-DF478EA8-0557-4D02-B16C-33DE237528CA

P2860

Q33739915-0A5E4458-DCBA-4105-899C-4680F35BEC34

Q33739915-2F09E4AB-72EC-41F8-9F12-CEB40443E0D9

Q33739915-398B6B06-077B-4602-86FA-D967CFD13087

Q33739915-3FE8A07A-7839-4203-8A01-A96A4AA77368

Q33739915-442682A5-76D7-4B92-8B53-70A5E58A0D4C

Q33739915-66BD904C-B91B-4548-9E7A-94E0FF4B3A1A

Q33739915-77BFE78B-6EAA-40A3-AB6A-316B90EA0FC5

Q33739915-8B873611-5EE2-43FB-8B70-D383899A7F8C

Q33739915-9AF5CC7C-1388-4122-8F84-0783893C6DAB

Q33739915-A0DEE3AC-0E9A-4443-9F15-4E55D2564048

P304

Q33739915-110D6D77-D594-43D7-833D-AC579D63C277

P31

Q33739915-9E1FA581-E23D-4FEE-9789-CC5EA89E831C

P356

Q33739915-4255ABB5-7FF7-4548-8598-61C64C6346DD

P407

Q33739915-CDEC88E6-343E-4CF5-BEC7-436666A957D4

P433

Q33739915-654A8FF0-176E-454A-AC9C-90E768A17802

P478

Q33739915-480181BD-6FFC-41C4-83A1-5155756D3842

P577

Q33739915-95C1B284-CFCF-46F4-A560-495F7BAC1AFD

P5875

Q33739915-AB548B8A-66E0-4D97-84B2-BBE25F4BE36A

P698

Q33739915-DA9D4E14-196D-4E1E-B6F1-4256937F8686

P932

Q33739915-39F35E84-F750-46D4-8485-CE2E425DA2CB

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Comparative pharmacokinetics of azlocillin and piperacillin in normal adults.

@en

P2093

Beightol LA

http://www.w3.org/2001/XMLSchema#string

Cefali EA

http://www.w3.org/2001/XMLSchema#string

Colaizzi PA

http://www.w3.org/2001/XMLSchema#string

Polk RE

http://www.w3.org/2001/XMLSchema#string

Poynor WJ

http://www.w3.org/2001/XMLSchema#string

Raffalovich AC

http://www.w3.org/2001/XMLSchema#string

P2860

GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity.

Pharmacokinetics of piperacillin following intravenous administration.

Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs.

High-performance liquid chromatographic determination of piperacillin in plasma.

Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.

Review of the pharmacokinetics and dose dependency of azlocillin in normal subjects and patients with renal insufficiency.

The acylampicillins: mezlocillin, piperacillin, and azlocillin.

Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.

Piperacillin: human pharmacokinetics after intravenous and intramuscular administration.

Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms.

P304

938-940

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.29.5.938

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

1986-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19433289

http://www.w3.org/2001/XMLSchema#string

P698

3729353

http://www.w3.org/2001/XMLSchema#string

P932

284187

http://www.w3.org/2001/XMLSchema#string